ConductScience.org, home

Paper69552

Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target.

Stevenson GT and 2 others. Fed Proc, 1977. Cited by 116 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target. Papers, record 69552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/69552

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target.
PubMed
Journal
Fed Proc
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
116
iCite
Relative citation ratio, by iCite
2.19
iCite
Revised in PubMed
2020-12-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stevenson GTG T
2Elliott EVE V
3Stevenson FKF K

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, Anti-IdiotypicMajor topic
B-LymphocytesMajor topic
Binding Sites, AntibodyMajor topic
Guinea PigsMajor topic
Immunoglobulin Variable RegionMajor topic
Leukemia, ExperimentalMajor topic
Leukemia, LymphoidMajor topic
Receptors, Antigen, B-CellMajor topic
Animals
Antigens, Neoplasm
Clone Cells
Epitopes
Humans
Immunoglobulin Allotypes
Immunoglobulin Fab Fragments
Immunoglobulin lambda-Chains
Immunoglobulin mu-Chains
Immunotherapy
Isoantibodies

Source PubMed

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00006184Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple MyelomaBackground

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.

PMIDTitleJournalYearIn PapersSource
40,275,113Identification, assembly and characterization of tumor immunoglobulin transcripts from RNA sequencing data using IgSeqR.Nat Protoc2025https://conductscience.org/library/papers/40275113PubMed
39,128,904Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial.Nat Commun2024https://conductscience.org/library/papers/39128904PubMed
37,345,057Recent Advances in Molecular Mechanisms of Cancer Immunotherapy.Cancers (Basel)2023https://conductscience.org/library/papers/37345057PubMed
29,439,670Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol.BMC Cancer2018https://conductscience.org/library/papers/29439670PubMed
25,755,905Towards an off-the-shelf vaccine therapy targeting shared B-cell tumor idiotypes.Am J Blood Res2014https://conductscience.org/library/papers/25755905PubMed
25,483,639Antigen-specific vaccines for cancer treatment.Hum Vaccin Immunother2014https://conductscience.org/library/papers/25483639PubMed
24,399,190Peptide vaccines for hematological malignancies: a missed promise?Int J Hematol2014https://conductscience.org/library/papers/24399190PubMed
23,264,902Trial watch: Peptide vaccines in cancer therapy.Oncoimmunology2012https://conductscience.org/library/papers/23264902PubMed
21,048,000Translating tumor antigens into cancer vaccines.Clin Vaccine Immunol2011https://conductscience.org/library/papers/21048000PubMed
20,848,095Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cells.Cancer Immunol Immunother2011https://conductscience.org/library/papers/20848095PubMed
20,425,407Vaccination strategies in follicular lymphoma.Curr Hematol Malig Rep2009https://conductscience.org/library/papers/20425407PubMed
18,422,783Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.Br J Haematol2008https://conductscience.org/library/papers/18422783PubMed
17,326,239Therapeutic vaccine for lymphoma.Yonsei Med J2007https://conductscience.org/library/papers/17326239PubMed
15,146,248Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes.J Clin Invest2004https://conductscience.org/library/papers/15146248PubMed
12,895,388Vaccination strategies for lymphomas.Curr Oncol Rep2003https://conductscience.org/library/papers/12895388PubMed
12,841,382Immunotherapy for lymphomas.Int J Hematol2003https://conductscience.org/library/papers/12841382PubMed
12,612,576Immunotherapy: past, present and future.Nat Med2003https://conductscience.org/library/papers/12612576PubMed
7,192,154Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces.Br J Cancer1980https://conductscience.org/library/papers/7192154PubMed
7,049,456The assessment of anti-idiopathic antibodies as effective immunoregulatory probes in vivo.Clin Exp Immunol1982https://conductscience.org/library/papers/7049456PubMed
6,970,174Antigenic modulation of lymphocytic surface immunoglobulin yielding resistance to complement-mediated lysis. I. Characterization with syngeneic and xenogeneic complements.Immunology1981https://conductscience.org/library/papers/6970174PubMed

See all 33 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/69552

GET https://conductscience.org/api/papers/v1/69552/cited_by?page=2